tiprankstipranks
Trending News
More News >
Artelo Biosciences Inc (ARTL)
NASDAQ:ARTL
US Market

Artelo Biosciences (ARTL) Financial Statements

Compare
545 Followers

Artelo Biosciences Financial Overview

Artelo Biosciences's market cap is currently $2.83M. The company's EPS TTM is $-3.97; its P/E ratio is -0.07; Artelo Biosciences is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-1.57. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -10.11M$ -9.93M$ -10.29M$ -7.44M$ -4.69M
EBITDA$ -10.11M$ -9.93M$ -10.08M$ -7.44M$ -4.69M
Net Income$ -9.83M$ -9.29M$ -10.08M$ -7.44M$ -4.66M
Balance Sheet
Cash & Short-Term Investments$ 2.34M$ 10.43M$ 17.53M$ 10.06M$ 2.14M
Total Assets$ 4.70M$ 13.04M$ 20.42M$ 12.63M$ 4.38M
Total Debt$ 104.00K$ 23.00K$ 63.00K$ 95.00K$ 0.00
Net Debt$ -2.23M$ -2.79M$ -6.83M$ -6.53M$ -2.14M
Total Liabilities$ 1.84M$ 1.29M$ 1.02M$ 593.00K$ 502.18K
Stockholders' Equity$ 2.86M$ 11.75M$ 19.40M$ 12.04M$ 3.87M
Cash Flow
Free Cash Flow$ -8.35M$ -8.21M$ -8.01M$ -6.14M$ -4.35M
Operating Cash Flow$ -8.35M$ -8.21M$ -8.01M$ -6.14M$ -4.35M
Investing Cash Flow$ 7.77M$ 3.51M$ 2.96M$ -3.44M$ 0.00
Financing Cash Flow$ 112.00K$ 567.00K$ 0.00$ 14.11M$ 1.98M
Currency in USD

Artelo Biosciences Earnings and Revenue History

Artelo Biosciences Debt to Assets

Artelo Biosciences Cash Flow

Artelo Biosciences Forecast EPS vs Actual EPS